Showing results (241-250 of 292) with videos related to
Sort By:
Pageof 30
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2011
Evaluation of the pharmacokinetic interaction between the dipeptidyl peptidase IV inhibitor LC15-0444 and pioglitazone in healthy volunteersSung Eun Kim, SoJeong Yi, Kwang-Hee Shin, et al.Journal of Clinical Pharmacology|February 13, 2013
Increased systemic exposure of fimasartan, an angiotensin II receptor antagonist, by ketoconazole and rifampicinJung Won Kim, SoJeong Yi, Tae-Eun Kim, et al.Clinical Therapeutics|November 4, 2011
Tolerability and pharmacokinetics of lobeglitazone (CKD-501), a peroxisome proliferator-activated receptor-γ agonist: a single- and multiple-dose, double-blind, randomized control study in healthy male Korean subjectsJung Won Kim, Jung-Ryul Kim, Sojeong Yi, et al.Annals of Laboratory Medicine|January 15, 2014
Quantification of human plasma-busulfan concentration by liquid chromatography-tandem mass spectrometrySoo Young Moon, Min Kyoo Lim, Susie Hong, et al.Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 13, 2003
Effect of peritoneal dialysis on plasma and peritoneal fluid concentrations of isoniazid, pyrazinamide, and rifampinCurie Ahn, Kook-Hwan Oh, Kiwon Kim, et al.International Journal of Clinical Pharmacology and Therapeutics|March 1, 2012
A positron emission tomography microdosing study with sertraline in healthy volunteersKwang-Hee Shin, Kyu-Pyo Kim, Kyoung Soo Lim, et al.Journal of Clinical Pharmacology|December 19, 2003
Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteersKyung-Sang Yu, Kyun-Seop Bae, Ji-Hong Shon, et al.British Journal of Clinical Pharmacology|March 6, 2008
Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjectsBo-Hyung Kim, Hyeong-Seok Lim, Jae-Yong Chung, et al.Clinical Therapeutics|March 9, 2010
Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteersBo-Hyung Kim, Kyu-Pyo Kim, Kyoung Soo Lim, et al.Clinical Pharmacology and Therapeutics|November 13, 2004
A variant 2677A allele of the MDR1 gene affects fexofenadine dispositionSo-Young Yi, Kyoung-Sup Hong, Hyeong-Seok Lim, et al.Pageof 30